Veracyte, Inc. financial data

Symbol
VCYT on Nasdaq
Industry
Services-Medical Laboratories
Location
6000 Shoreline Court, Suite 300, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CALDEROME INC (to 2/27/2008)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 479 % +8.68%
Quick Ratio 28.3 % +20.2%
Debt-to-equity 7.9 % +10.7%
Return On Equity -0.83 % +82.3%
Return On Assets -0.77 % +82.4%
Operating Margin -5.53 % +65.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.5M shares +6.11%
Common Stock, Shares, Outstanding 77.5M shares +6.16%
Entity Public Float 1.7B USD +21.4%
Common Stock, Value, Issued 77K USD +5.48%
Weighted Average Number of Shares Outstanding, Basic 77M shares +5.78%
Weighted Average Number of Shares Outstanding, Diluted 78.5M shares +7.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 425M USD +23.9%
Research and Development Expense 68.7M USD +37.6%
Selling and Marketing Expense 95.9M USD -4.47%
General and Administrative Expense 107M USD +39%
Costs and Expenses 442M USD +33.3%
Operating Income (Loss) -23.5M USD +57.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.17M USD +83.5%
Income Tax Expense (Benefit) 1.69K USD
Net Income (Loss) Attributable to Parent -9.27M USD +81.4%
Earnings Per Share, Basic -0.13 USD/shares +81.4%
Earnings Per Share, Diluted -0.14 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 274M USD +35.4%
Cash, Cash Equivalents, and Short-term Investments 217M USD +21%
Accounts Receivable, after Allowance for Credit Loss, Current 48.8M USD +24.2%
Inventory, Net 20.4M USD +28.2%
Assets, Current 357M USD +31.6%
Property, Plant and Equipment, Net 17.7M USD +17.2%
Operating Lease, Right-of-Use Asset 17M USD +50.8%
Intangible Assets, Net (Excluding Goodwill) 109M USD -11.9%
Other Assets, Noncurrent 7.87M USD +41%
Assets 1.28B USD +13.3%
Accounts Payable, Current 9.67M USD -22.8%
Employee-related Liabilities, Current 30.7M USD +17.9%
Accrued Liabilities, Current 43.9M USD +26%
Contract with Customer, Liability, Current 2.03M USD -8.18%
Liabilities, Current 70.3M USD +22.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 1.47M USD -59.7%
Operating Lease, Liability, Noncurrent 12.4M USD +42.2%
Other Liabilities, Noncurrent 571K USD -26.4%
Liabilities 99M USD +39.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -21.3M USD +37.8%
Retained Earnings (Accumulated Deficit) -449M USD -2.11%
Stockholders' Equity Attributable to Parent 1.18B USD +11.6%
Liabilities and Equity 1.28B USD +13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.97M USD -313%
Net Cash Provided by (Used in) Financing Activities -864K USD -151%
Net Cash Provided by (Used in) Investing Activities 2.88M USD -88%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 77.5M shares +6.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.06M USD -130%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 275M USD +35.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Gross 163M USD +3.32%
Operating Lease, Liability 19.7M USD +43.5%
Payments to Acquire Property, Plant, and Equipment 2.13M USD +115%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.65M USD
Lessee, Operating Lease, Liability, to be Paid 27.5M USD +79.7%
Property, Plant and Equipment, Gross 43.7M USD +19.4%
Operating Lease, Liability, Current 7.29M USD +45.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.28M USD -42.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.83M USD +39.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +25%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.83M USD +393%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.03M USD +43.7%
Deferred Tax Assets, Operating Loss Carryforwards 111M USD -12.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 5.69M USD +16.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2M USD +236%
Operating Lease, Payments 6.59M USD +29.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 15.9M USD -25%
Depreciation, Depletion and Amortization 5.59M USD -16.2%
Deferred Tax Assets, Net of Valuation Allowance 22.9M USD -28.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%